2015 Recalls and Alerts



12/18/2015 - Baxter International, Inc. 
Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter

10/22/2015 - FDA Safety Alert: Kayexalate 
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies

9/21/2015 - US Compounding, Inc.
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products

9/9/2015 - Medistat RX, LLC
FDA Announces Medistat RX’s Nationwide Voluntary Recall of Sterile Drug Products

8/27/2015 - Insulet Corporation
Insulet Corporation Issues Voluntary Recall of OmniPod® Insulin Management System

7/30/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Nationwide Recall of One Lot of IV Solution Due to the Potential For Leaking Containers, Particulate Matter and Missing Port Protectors

7/17/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall Of Two Lots Of IV Solutions Due To The Potential Presence Of Particulate Matter

4/10/2015 - Baxter International, Inc.
Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter

01/20/15 - Hospira, Inc.
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, 250 mL Due to Particulate Matter